Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)
CIMA — Centro de Información de Medicamentos · Spain
- Updated
- Not provided for this source record
- Synchronized
- Oct 2, 2026
Medicine · Spain
GLYCOPHOS 216 MG/ML CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Injection
Home Med Cabinet
Updated · Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) — Not provided for this source record
Synchronized
At a glance
- Active ingredient
- GLICEROFOSFATO SODIO — 216 mg
- Pharmaceutical form Home Med Cabinet grouping
- Injection
- Availability in Spain
- 1 of 2 packs marketed
Packs
GLYCOPHOS 216 MG/ML CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN,20 ampollas de 20 ml
20 ampoules
National code
Marketed728213Strength of this pack 216 mg
GLYCOPHOS 216 MG/ML CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN, 10 viales de 20 ml
10 pcs
National code
Not marketed963207Strength of this pack 216 mg
“Marketed” means the authority records the pack as placed on the market. It is not a statement about pharmacy stock.
Official documents
Documents open on the authority’s own site. Home Med Cabinet links to them and hosts no copy.
- Official
Opens on the authority’s own site
- Official
Summary of product characteristics
Opens on the authority’s own site
Registration
- Registration number
- 64328Official data
- Marketing authorisation holder
- FRESENIUS KABI ESPAÑA, S.A.U.Official data
- Authorised
- Oct 25, 2001Official data
- Authority form code
- 197Official data
Classification
ATC classification is not published here yet
Publication rights for ATC codes and labels are still under review, and no classification is inferred for this record.